Ghost Tree Capital, LLC Astria Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$6.99 - $16.69 $1.54 Million - $3.67 Million	-220,000 Reduced 65.67%	115,000 $1.62 Million
Q4 2023 Feb 14, 2024	BUY	$4.42 - $8.06 $154,700 - $282,100	35,000 Added 11.67%	335,000 $2.57 Million
Q3 2023 Nov 14, 2023	SELL	$6.89 - $9.86 $1,191 - $1,705	-173 Reduced 0.06%	300,000 $2.24 Million
Q2 2023 Aug 14, 2023	SELL	$8.33 - $13.72 $1.25 Million - $2.06 Million	-149,827 Reduced 33.29%	300,173 $2.5 Million
Q4 2022 Feb 14, 2023	SELL	$7.44 - $14.89 $372,000 - $744,500	-50,000 Reduced 10.0%	450,000 $6.7 Million
Q3 2022 Nov 14, 2022	BUY	$2.97 - $10.34 $1.49 Million - $5.17 Million	500,000 New	500,000 $4.52 Million

107

48.6M

48K

9.3K

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $143M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.